Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: A multi-center prospective randomized open-label blinded-endpoint trial

Jing-ya Li; Li-xin Yuan; Gen-ming Zhang; Li Zhou; Ying Gao; Qing-bin Li; Che Chen

doi:10.1007/s11655-016-2467-7

Your Location：

Home >

Browse articles >

Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: A multi-center prospective randomized open-label blinded-endpoint trial

OriginalPaper | Updated：2021-08-27

- Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: A multi-center prospective randomized open-label blinded-endpoint trial
- Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: A multi-center prospective randomized open-label blinded-endpoint trial
- 中国结合医学杂志（英文版） 2016年22卷第5期页码：328-334
- Affiliations：
  
  1. Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Beijing,China
  2. Tongzhou Traditional Chinese Medicine Hospital of Beijing,Beijing,China
- Author bio：
- Funds：
  
  Supported by the Beijing Committee on Science and Technology, Project on Research on Two Standards of Traditional Chinese Medicine Treatment for Stroke (No. D101107049310003)
- DOI：10.1007/s11655-016-2467-7
  中图分类号：
- 纸质出版日期：2016，
  
  网络出版日期：2016-4-30，
Scan for full text
Li, Jy., Yuan, Lx., Zhang, Gm. et al. Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: A multi-center prospective randomized open-label blinded-endpoint trial., Chin. J. Integr. Med. 22, 328–334 (2016). https://doi.org/10.1007/s11655-016-2467-7

Jing-ya Li, Li-xin Yuan, Gen-ming Zhang, et al. Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: A multi-center prospective randomized open-label blinded-endpoint trial[J]. Chinese Journal of Integrative Medicine, 2016,22(5):328-334.
Li, Jy., Yuan, Lx., Zhang, Gm. et al. Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: A multi-center prospective randomized open-label blinded-endpoint trial., Chin. J. Integr. Med. 22, 328–334 (2016). https://doi.org/10.1007/s11655-016-2467-7 DOI：

Jing-ya Li, Li-xin Yuan, Gen-ming Zhang, et al. Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: A multi-center prospective randomized open-label blinded-endpoint trial[J]. Chinese Journal of Integrative Medicine, 2016,22(5):328-334. DOI： 10.1007/s11655-016-2467-7.

摘要

To investigate the efficacy and safety of the Chinese herbal therapeutic regimen of activating blood circulation (TRABC) in treatment of hypertensive intracerebral hemorrhage (HICH). This was a multi-center prospective randomized open-label blinded-endpoint (PROBE) trial with HICH admitted to 12 hospitals. Totally 240 participants were randomized to the treatment group treated with TRABC in addition to conventional Western treatment or the control group with conventional Western treatment equally for 3 months. Primary outcome was degree of disability as measured by modified Rankin Scale (mRS). Secondary outcomes were the absorption of hematoma and edema

National Institutes of Health Stroke Scale (NIHSS) scores and patient-reported outcome measures for stroke and Barthel activities of daily living index. Adverse events and mortality were also recorded. After 3 months of treatment

the rate of mRS 0-1 and mRS 0-2 in the treatment group was 72.5% and 80.4%

respectively

and in the control group 48.1% and 63.9%

respectively

with a significant difference between groups (P<0.01). Hematoma volume decreased significantly at day 7 of treatment in the treatment group than the control group (P=0.038). Average Barthel scores in the treatment group after treatment was 89.11±19.93

and in the control group 82.18±24.02 (P=0.003). NIHSS scores of the two groups after treatment decreased significantly compared with before treatment (P=0.001). Patient-reported outcomes in the treatment group were lower than the control group at day 21 and 3 months of treatment (P<0.05). There were 4 deaths

2 in each group

and 11 adverse events

6 in the treatment group and 5 in the control group. The integrative therapy combined TRABC with conventional Western treatment for HICH could promote hematoma absorption thus minimize neurologic impairment

without increasing intracerebral hematoma expansion and re-bleeding.

Abstract

the rate of mRS 0-1 and mRS 0-2 in the treatment group was 72.5% and 80.4%

respectively

and in the control group 48.1% and 63.9%

respectively

2 in each group

and 11 adverse events

without increasing intracerebral hematoma expansion and re-bleeding.

关键词

hypertensive intracerebral hemorrhageactivating blood circulation to remove stasisChinese herbsprospective randomized open-label blinded-endpoint trial

Keywords

hypertensive intracerebral hemorrhageactivating blood circulation to remove stasisChinese herbsprospective randomized open-label blinded-endpoint trial

references

Cheung RT. Update on medical and surgical management of intracerebral hemorrhage. Rev Recent Clin Trials 2007;2:174–181.

Zurasky JA, Aiyagari V, Zazulia AR, Shackelford A, Diringe MN. Early mortality following spontaneous intracerebral hemorrhage. Neurology 2005;64:725–727.

Kuramatsu JB, Huttner HB, Schwab S. Advances in the management of intracerebral hemorrhage. J Neural Transm 2013;120 (Suppl) 1:S35–S41.

Jade WW, Huang YN, Wang JG, Liu M, Lawrence KSW, Huang QF, et al. Current management of intracerebral hemorrhage in China: a national, multi-centre, hospital registers study. BMC Neurol 2011;11:16.

Cui JT, Liu JX. Research of integrated Chinese and Western medicine in treatment of hypertensive cerebral hemorrhage. J Hubei Univ Chin Med (Chin) 2014;1:115–117.

Fan ML, Zhou GX. Effects of Xingnaojing on cerebral edema and the expressions of matrix metalloproteinase-9 and complement 3 around hematoma after intracerebral hemorrhage in rats. Chin J Contemp Neurol Neurosurg (Chin) 2009;3:284–289.

Zhou QB, LI LY, Jia Q. Protective effect of Naoningkang Granule on brain in intracerebral hemorrhagic rats. Chin J Integr Tradit West Med (Chin) 2007;9:814–818.

Feng Z, Lou YY. Curative effect observation of the integrative medicine on treating cerebral hemorrhage. Clin J Chin Med (Chin) 2013;17:8–10.

An B, Jiang YC, Kang XH, Cao F, Chen GH. Clinical study of Shuanghuang Tongfu Granules in treatment of intracerebral hemorrhage. Hubei J Tradit Chin Med (Chin) 2014;36:9–10.

Chen ZG, Wang SL, Meng FX, Han G, Lin S, Guo RJ, et al. Retrospective analysis of acute hemorrhagic stroke treated with the method of activating blood circulation to remove stasis. Chin J Inf Tradit Chin Med (Chin) 2007;14(7):15–17.

Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 2007;38:1091–1096.

Bae C, Andrefsky JC, Degeorgia MA. NIHSS predicts outcome better than GCS in intracerebral hemorrhage. Stroke 2001;32:356–357.

Chinese Society of Neurology. Chinese Cerebrovascular Disease Guideline, 2005. J Apoplexy Nerv Dis (Chin) 2006;23:132-134.

Zhang C, Gao Y. Current issues in application of the standards for syndrome differentiation and diagnosis of stroke. Tianjin J Tradit Chin Med (Chin) 2007;24:12–14.

Zhu Y, Qi S, Wu H, Xiang Z. Study on the improvement of Coniglobus formula based on subdural hematoma volume estimates. Neurosurgery Quarterly 2015;25:275–279.

Gian Luca DP, Katia S, Elodie O, Monica R, Francesco M, Leone MA. Validity and reliability of the Barthel index administered by telephone. Stroke 2011;42:2077–2079.

Zhang GM, Zhou L, Cui FY, Chen Y, Chen H, Cen K, et al. Etiology and pathophysiology of hemorrhagic stroke. Chin J Integr Med Cardio-Cerebrovasc Dis (Chin) 2013;11:87–88.

Zhang GM, Zhou L, Ma B, Cui FY, Chen H. Traditional Chinese medicine treatment of cerebral hemorrhage based on activating blood circulation to remove stasis: methodology and theoretic basis. Chin J Pharmacovigil (Chin) 2013;10:352–354.

Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 2006;5:53–63.

Yang WM, Li QL. Current status of application of activating blood circulation to remove stasis in treatment of acute cerebral hemorrhage. Clin J Tradit Chin Med (Chin) 2010;22:944–947.

Liu H, Zhang GP, Song SJ, Ding MP, Zhou JF, Bie XD, et al. Clinical study on Zhuyu Tongfu Serial Recipe combined with acupuncture and massotherapy in treating hypertensive cerebral hemorrhage. Chin J Integr Tradit West Med (Chin) 2005;11:167–172.

Zhu DS, Xu MH, Wei HC. Traditional Chinese prescriptions for treatment of acute cerebral hemorrhage. Chin J Integr Tradit West Med Intens Critic Care (Chin) 2000;7:133–136.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

A Data Mining-Based Study on Medication Rules of Chinese Herbs to Treat Heart Failure with Preserved Ejection Fraction

Stabilizing the bactericidal activity of hydrogen peroxide: A brandnew function of certain Chinese herbs

Antifibrotic effect of the Chinese herbs Modified Danggui Buxue Decoction (加味当归补血汤) on adriamycin-induced nephropathy in rats

A microarray analysis of angiogenesis modulation effect of Xuefu Zhuyu Decoction (血府逐瘀汤) on endothelial cells

Evolution of the management of colorectal cancer using integrative medicine